Gooc, Geneveve T.

HRN: 22-96-41  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2023
AMPICILLIN 1GM (VIAL)
05/11/2023
05/18/2023
IV
2gms
Q6
Prom
Waiting Final Action 
05/11/2023
METRONIDAZOLE 500MG (TAB)
05/11/2023
05/18/2023
PO
500mg
TID
Bacterial Vaginosis
Waiting Final Action 
05/11/2023
CO-AMOXICLAV 625MG (TAB)
05/11/2023
05/18/2023
ORAL
625mg
BID
Aub; Uti
Waiting Final Action 
05/12/2023
CEFUROXIME 500MG (TAB)
05/12/2023
05/19/2023
PO
500mg
BID
Episiorraphy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: